TG Therapeutics, Inc. (TGTX)
55.85
+2.81
(+5.30%)
USD |
NASDAQ |
Sep 16, 16:00
56.15
+0.30
(+0.54%)
After-Hours: 05:47
TG Therapeutics Total Return Level : 55.85 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 55.85 |
| September 15, 2026 | 53.04 |
| September 14, 2026 | 54.00 |
| September 11, 2026 | 53.89 |
| September 10, 2026 | 55.39 |
| September 09, 2026 | 54.65 |
| September 08, 2026 | 55.74 |
| September 04, 2026 | 55.98 |
| September 03, 2026 | 56.71 |
| September 02, 2026 | 56.90 |
| September 01, 2026 | 56.09 |
| August 31, 2026 | 54.30 |
| August 28, 2026 | 53.93 |
| August 27, 2026 | 55.72 |
| August 26, 2026 | 55.03 |
| August 25, 2026 | 55.42 |
| August 24, 2026 | 56.01 |
| August 21, 2026 | 54.27 |
| August 20, 2026 | 50.56 |
| August 19, 2026 | 51.69 |
| August 18, 2026 | 50.26 |
| August 17, 2026 | 49.28 |
| August 14, 2026 | 48.74 |
| August 13, 2026 | 47.94 |
| August 12, 2026 | 49.50 |
| Date | Value |
|---|---|
| August 11, 2026 | 49.90 |
| August 10, 2026 | 49.16 |
| August 07, 2026 | 49.76 |
| August 06, 2026 | 49.55 |
| August 05, 2026 | 49.88 |
| August 04, 2026 | 48.74 |
| August 03, 2026 | 46.17 |
| July 31, 2026 | 52.03 |
| July 30, 2026 | 53.53 |
| July 29, 2026 | 53.48 |
| July 28, 2026 | 54.87 |
| July 27, 2026 | 55.75 |
| July 24, 2026 | 56.04 |
| July 23, 2026 | 55.50 |
| July 22, 2026 | 52.68 |
| July 21, 2026 | 53.95 |
| July 20, 2026 | 53.96 |
| July 17, 2026 | 54.87 |
| July 16, 2026 | 54.93 |
| July 15, 2026 | 56.41 |
| July 14, 2026 | 54.89 |
| July 13, 2026 | 55.01 |
| July 10, 2026 | 57.12 |
| July 09, 2026 | 59.06 |
| July 08, 2026 | 57.23 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Krystal Biotech, Inc. | 336.67 |
| Alnylam Pharmaceuticals, Inc. | 239.36 |
| BioMarin Pharmaceutical, Inc. | 64.73 |
| Cytokinetics, Inc. | 69.39 |
| Exelixis, Inc. | 56.78 |